Financhill
Back

PDS Biotechnology Quote, Financials, Valuation and Earnings

7 Powerhouse Stocks to Buy and Hold Forever

Get it now.
Sell
47

PDSB
PDS Biotechnology

Last Price:
3.28
Seasonality Move:
44.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Election Shock on August 19th?

Click here now to see the evidence I've gathered.

PDS Biotechnology Price Quote

$3.28
+0.01 (+0.61%)
(Updated: April 27, 2024 at 6:16 AM ET)

PDS Biotechnology Key Stats

Sell
47
PDS Biotechnology (PDSB) is a Sell

Day range:
$3.20 - $3.38
52-week range:
$2.59 - $10.27
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.59%

Volume:
415.4K
Avg. volume:
982.6K
1-year change:
-44.76%
Market cap:
$119.9M
Revenue:
$0
EPS:
$-1.39

How Much Does PDS Biotechnology Make?

Data Unavailable

Is PDS Biotechnology Growing As A Company?

Data Unavailable

PDS Biotechnology Stock Price Performance

  • Did PDS Biotechnology Stock Go Up Last Month?
    PDS Biotechnology share price went down by -27.01% last month
  • Did PDSB's Share Price Rise Over The Last Year?
    PDSB share price fell by -44.76% over the past 1 year

What Is PDS Biotechnology 52-Week High & Low?

PDS Biotechnology Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy PDS Biotechnology?

  • How Much Debt Does PDS Biotechnology Have?
    Total long term debt quarterly is $0
  • How Much Cash Does PDS Biotechnology Have?
    Cash and short term investments quarterly total is $56.6M
  • What Is PDS Biotechnology’s Book Value Per Share?
    Book value per share is 0.79

Is PDS Biotechnology Cash Flow Positive?

  • What Is PDSB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$33.6M
  • What Is PDS Biotechnology’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $16.4M
  • What Is PDS Biotechnology’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

PDS Biotechnology Return On Invested Capital

Data Unavailable

PDS Biotechnology Earnings Date & Stock Price

PDS Biotechnology Competitors

PDS Biotechnology Dividend Yield

Data Unavailable

PDS Biotechnology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 16.27%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 14.40
Upside from Last Price: 340.37%

Major Shareholders

  • How many PDSB shares are owned by institutional investors?
    12.9M PDSB shares are owned by institutional investors
  • How many PDSB shares are owned by insiders?
    3M PDSB shares are owned by insiders